We set out to determine the optimal intraoperative treatment algorithm to lower glucose in patients with DM type @ undergoing non-cardiac surgery , comparing intraoperative glucose-insulin-potassium infusion ( GIK ) , insulin bolus regimen ( BR ) and GPL-@ ( liragludite , LG ) treatment .